SpyGlass Pharma

United States
90 Total Employees
Year Founded: 2019
SpyGlass Pharma is a late-stage biopharmaceutical company developing sustained drug-delivery treatments for chronic eye disease, especially glaucoma. Its lead BIM-IOL System combines bimatoprost delivery with an intraocular lens implanted during routine cataract surgery, aiming to provide long-term intraocular-pressure control while preserving vision and reducing reliance on daily eye drops. The company is also advancing a delivery system for glaucoma patients beyond cataract surgery.

Recently Posted Jobs at SpyGlass Pharma

SpyGlass Pharma Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site:
United States